Your browser doesn't support javascript.
loading
Changes in the global impact of COVID-19 on nuclear medicine departments during 2020: an international follow-up survey.
Giammarile, Francesco; Delgado Bolton, Roberto C; El-Haj, Noura; Freudenberg, Lutz S; Herrmann, Ken; Mikhail, Miriam; Morozova, Olga; Orellana, Pilar; Pellet, Olivier; Estrada L, Enrique; Vinjamuri, Sobhan; Gnanasegaran, Gopinath; Pynda, Yaroslav; Navarro-Marulanda, Maria C; Choudhury, Partha S; Paez, Diana.
Afiliación
  • Giammarile F; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400, Vienna, Austria. f.giammarile@iaea.org.
  • Delgado Bolton RC; Department of Diagnostic Imaging (Radiology) and Nuclear Medicine, University Hospital San Pedro and Centre for Biomedical Research of La Rioja (CIBIR), Logroño, La Rioja, Spain.
  • El-Haj N; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400, Vienna, Austria.
  • Freudenberg LS; ZRN Rheinland and ZRN MVZ GmbH, Korschenbroich, Germany.
  • Herrmann K; Department of Nuclear Medicine, University Hospital Essen, Essen, Germany.
  • Mikhail M; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400, Vienna, Austria.
  • Morozova O; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400, Vienna, Austria.
  • Orellana P; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400, Vienna, Austria.
  • Pellet O; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400, Vienna, Austria.
  • Estrada L E; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400, Vienna, Austria.
  • Vinjamuri S; Nuclear Medicine Department, Liverpool University Hospitals, Liverpool, UK.
  • Gnanasegaran G; Nuclear Medicine Department, Royal Free London, London, UK.
  • Pynda Y; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400, Vienna, Austria.
  • Navarro-Marulanda MC; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400, Vienna, Austria.
  • Choudhury PS; Nuclear Medicine Department, Rajiv Gandhi Cancer Institute, Delhi, India.
  • Paez D; Nuclear Medicine and Diagnostic Imaging Section, Division of Human Health, Department of Nuclear Sciences and Applications, International Atomic Energy Agency, 1400, Vienna, Austria.
Eur J Nucl Med Mol Imaging ; 48(13): 4318-4330, 2021 12.
Article en En | MEDLINE | ID: mdl-34148118
ABSTRACT

AIM:

As a follow-up to the international survey conducted by the International Atomic Energy Agency (IAEA) in April 2020, this survey aims to provide a situational snapshot of the COVID-19 impact on nuclear medicine services worldwide, 1 year later. The survey was designed to determine the impact of the pandemic at two specific time points June and October 2020, and compare them to the previously collected data. MATERIALS AND

METHODS:

A web-based questionnaire, in the same format as the April 2020 survey was disseminated to nuclear medicine facilities worldwide. Survey data was collected using a secure software platform hosted by the IAEA; it was made available for 6 weeks, from November 23 to December 31, 2020.

RESULTS:

From 505 replies received from 96 countries, data was extracted from 355 questionnaires (of which 338 were fully completed). The responses came from centres across varying regions of the world and with heterogeneous income distributions. Regional differences and challenges across the world were identified and analysed. Globally, the volume of nuclear medicine procedures decreased by 73.3% in June 2020 and 56.9% in October 2020. Among the nuclear medicine procedures, oncological PET studies showed less of a decline in utilization compared to conventional nuclear medicine, particularly nuclear cardiology. The negative impact was also significantly less pronounced in high-income countries. A trend towards a gradual return to the pre-COVID-19 situation of the supply chains of radioisotopes, generators, and other essential materials was evident.

CONCLUSION:

The year 2020 has a significant decrease in nuclear medicine diagnostic and therapeutic procedures as a result of the pandemic-related challenges. In June, the global decline recorded in the survey was greater than in October when the situation began to show improvement. However, the total number of procedures remained below those recorded in April 2020 and fell to less than half of the volumes normally carried out pre-pandemic.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Medicina Nuclear Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Austria

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: COVID-19 / Medicina Nuclear Tipo de estudio: Observational_studies / Prognostic_studies Límite: Humans Idioma: En Revista: Eur J Nucl Med Mol Imaging Asunto de la revista: MEDICINA NUCLEAR Año: 2021 Tipo del documento: Article País de afiliación: Austria